| Similar Articles |
|---|
 |
Chemistry World
October 29, 2014
Phillip Broadwith |
Judge slashes fines in drug safety case A US judge has once again overturned a jury's decision to extract massive damages from pharmaceutical firms Takeda and Eli Lilly in a case concerning diabetes drug Actos (pioglitazone).   |
Chemistry World
May 3, 2013
Phillip Broadwith |
Judge reverses jury decision over $6.5m Takeda payout A judge has thrown out the jury's verdict in a case between Japanese drugmaker Takeda and a US man who claims that the company's drug caused his bladder cancer. |
Chemistry World
April 11, 2014
Andy Extance |
Missing safety risk emails draw $9bn Actos fine A US jury has fined Takeda and Eli Lilly $9 billion for causing a man's bladder cancer with their diabetes drug Actos (pioglitazone). |
Chemistry World
September 24, 2010
Andrew Turley |
End of the road for Avandia? The European Medicines Agency has decided the troubled diabetes drug should be pulled from the market while the US Food and Drug Administration has said it will 'significantly restrict' its use. |
Chemistry World
August 20, 2012 |
Generic Actos Approved Three generics manufacturers - Mylan, Ranbaxy and Teva - have won US marketing approval for their generic versions of Actos diabetes tablets. |
The Motley Fool
June 30, 2011
David Williamson |
Biotech Takes On the Next Big Problem The news coming out of this week's annual conference of the American Diabetes Association wasn't good. |
Chemistry World
May 20, 2011
Sarah Houlton |
Takeda expands into Europe with Nycomed deal Japanese pharma company Takeda is to acquire Swiss-headquartered rival Nycomed for 9.6 billion. If the antitrust authorities give the go-ahead, the takeover should be completed by late summer. |
Chemistry World
January 20, 2012
Sarah Houlton |
Takeda slashes 10% of its workforce This represents about 10% of its workforce, and the cuts will be made in research, commercial and admin sections of the business. |
Investment Advisor
April 2009
James J. Green |
B/D Briefing: Calm Before the Storm? A new report found that the average securities class action settlement was halved in 2008, but the authors of Securities Class Action Settlements: 2008 Review and Analysis, caution that the reported decrease doesn't constitute a trend. |
InternetNews
August 31, 2004
Michael Singer |
Calif. Cities Sue Microsoft For Overcharging San Francisco, Los Angeles and a handful of counties file a class action lawsuit seeking separate damages than the state's landmark $1.1 billion settlement. |
Chemistry World
November 7, 2012
Andrew Turley |
Takeda buys Envoy for $140m The move gives Takeda access to Envoy's 'BacTrap' technology for labeling and extracting the protein-making components of specific types of cells. |
Chemistry World
June 14, 2013
Phillip Broadwith |
Pfizer and Takeda win $2.15bn in patent payout Pfizer and Takeda will share a $2.15 billion settlement after suing generic drugmakers Teva and Sun Pharmaceuticals for patent infringement. |
Chemistry World
August 16, 2013
Dinsa Sachan |
Indian U-turn on diabetes drug ban In June the Indian government suspended the popular diabetes drug, pioglitazone, over safety concerns only to revoke the suspension a little over a month later. |
On Wall Street
January 1, 2009
Alan J. Foxman |
Reimbursing Your Firm Advisors are unsure how to split the cost of damages from a complaint -- and when a settlement goes on the U-4. |
The Motley Fool
August 15, 2007
Billy Fisher |
Adversity Continues for Avandia Avandia and Actos receive black box labels from the FDA. The two diabetes medications have been linked to an increase in heart failure. |
IndustryWeek
August 1, 2007
Brad Kenney |
Are You A Software Pirate And You Don't Even Know It? Business Software Alliance aims to stem the tide of pirated business software in manufacturing. |
Information Today
October 11, 2012
George H. Pike |
Google's Settlement With Publishers Does Not Resolve All Library Project Issues After more than 7 years of litigation, Google and The Association of American Publishers reached a settlement over Google's ongoing Library Project to scan books from public and academic libraries and make the content available over Google. |
AskMen.com
Michael Estrin |
How To: Sue Sometimes you just have to go to court. Here are some tips to help you navigate the difficult waters of litigation. |
Information Today
September 24, 2009 |
Google Book Search Settlement Hearing to Be Postponed On Sept. 22, the parties involved in the Google Book Search settlement have asked the federal court to postpone the scheduled Oct. 7 hearing to give them time to work with the U.S. Department of Justice so that the parties can amend the Settlement Agreement. |
Investment Advisor
May 2010
Melanie Waddell |
Settlements On Rise The total value and number of securities class action settlements increased in 2009 to $3.8 billion. |
Chemistry World
May 30, 2012 |
Takeda buys into Brazil for 540m reals Brazilian company Multilab made sales of BRL140 million in 2011, primarily from generics and over-the-counter branded products, including its leading cold and flu brand Multigrip. |
On Wall Street
October 1, 2009
Thomas O. Gorman |
SEC v. Bank of America: Where to Go From Here? The SEC thought it had completed an investigation, brought an enforcement action and then settled it. |
Chemistry World
July 16, 2010
Matt Wilkinson |
Bittersweet victory for GSK's Avandia GlaxoSmithKline has received a muted 'thumbs up' from a US regulatory advisory panel for its much-maligned Type 2 diabetes drug Avandia (rosiglitazone), making it likely the US Food and Drug Administration will allow the UK-based pharma giant to continue selling the drug in the US. |
Financial Advisor
May 2006
Bruce W. Fraser |
An Undiscovered Asset Class Most advisors know little about the structured settlements market, yet the dollar amounts in settlements can range into the millions of dollars, thus making them a potentially profitable niche market for wealth managers and other fee-only advisors. |
Financial Planning
June 1, 2005
DeFrancesco & Salani |
A Hidden Asset How clients can turn life insurance into cold, hard cash while they're still alive. |
OCC Bulletin
April 21, 2006 |
Guidance for Filing Notices of Proposed Class Action Settlements New notification requirements apply to a wide range of federal and state depository institutions, and entities thereof, that are defendants in proposed class action settlements. |
Chemistry World
September 6, 2013
Dinsa Sachan |
Another drug suspension overturned in India An Indian high court has quashed the suspension of a popular antidepressant. This comes shortly after the suspension of the diabetes drug pioglitazone was overturned. |
InternetNews
July 1, 2004
Erin Joyce |
For Free-and-Clear Microsoft, What's Next? A federal court decided Microsoft won't face new sanctions for abusing its monopoly in the U.S.; does that mean Redmond is free to monopolize? |
The Motley Fool
February 21, 2007
Mary Dalrymple |
Life Settlements Laid Out Understand this new marketplace before considering selling your life insurance. |
InternetNews
September 25, 2009 |
Judge's Order Keeps Google Books in Limbo New York judge postpones fairness hearing for controversial settlement agreement in response to DoJ objections. |
Chemistry World
June 4, 2015
Phillip Broadwith |
Takeda to consolidate vaccines business in Boston Japanese pharma firm Takeda plans to close three US sites and move the headquarters of its vaccines business unit to the pharmaceutical hub in the Boston and Cambridge area of Massachusetts. |
The Motley Fool
September 12, 2005
Brian Gorman |
Mixed Diagnosis for Bristol-Myers Positive news on two drugs is reason to celebrate, but investors may want to keep their enthusiasm in check. |
Financial Advisor
April 2006
Bruce W. Fraser |
Cashing In On Cashing Out Despite the potential for abuse, life settlements (selling life insurance policies early) is a growing industry and may be a viable option for insured seniors and advisors alike -- under the right circumstances. |
The Motley Fool
June 9, 2011
Brian Orelli |
XOMA Breaks Bad News to Investors XOMA 052 continues to be a disaster in diabetes. |
